EWTX - Edgewise Therapeutics, Inc.

QQQ $ 609.00 $ -9.26 (-1.5 %)

DIA $ 475.42 $ -6.59 (-1.37 %)

SPY $ 672.87 $ -8.41 (-1.24 %)

TLT $ 89.38 $ -0.42 (-0.46 %)

GLD $ 385.24 $ -4.31 (-1.11 %)

Previous Close

$ 20.42

Open

$ 20.79

Bid

$ 19.86 x 502

Ask

$ 21.54 x 250

Day's Range

$ 19.87 - $ 21.16

52 Week Range

$ 10.60 - $ 35.50

Volume

1,088,537

Average Volume

Market Cap

2.16B

Beta (5Y Monthly)

$ 1.60

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-08-2025	03-31-2025	10-Q
4	03-03-2025	12-31-2024	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-09-2024	03-31-2024	10-Q
8	02-22-2024	12-31-2023	10-K
9	11-09-2023	09-30-2023	10-Q
10	08-10-2023	06-30-2023	10-Q
11	05-11-2023	03-31-2023	10-Q
12	02-23-2023	12-31-2022	10-K
13	11-03-2022	09-30-2022	10-Q
14	08-04-2022	06-30-2022	10-Q
15	05-11-2022	03-31-2022	10-Q
16	02-24-2022	12-31-2021	10-K
17	11-10-2021	09-30-2021	10-Q
18	08-09-2021	06-30-2021	10-Q
19	05-13-2021	03-31-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Edgewise Therapeutics Appoints Michael Nof...
11/10/2025 13:14:45

RBC Capital Maintains Outperform on Edgewi...
11/07/2025 18:55:35

RBC Capital analyst Leonid Timashev maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and raises the price tar...

Wedbush Maintains Outperform on Edgewise T...
11/07/2025 15:05:41

Wedbush analyst Laura Chico maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and lowers the price target from...

Edgewise Therapeutics Q3 EPS $(0.39) Beats...
11/06/2025 13:30:10

Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of...

JP Morgan Maintains Overweight on Edgewise...
08/19/2025 14:31:35

JP Morgan analyst Tessa Romero maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Overweight and lowers the price target f...

RBC Capital Maintains Outperform on Edgewi...
08/08/2025 17:44:57

RBC Capital analyst Leonid Timashev maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and raises the price tar...

Edgewise Therapeutics Q2 EPS $(0.34) Beats...
08/07/2025 12:11:00

Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of...

this-starbucks-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday

This Starbucks Analyst Begins Coverage On ...
06/30/2025 17:04:18

HC Wainwright & Co. Initiates Coverage On ...
06/30/2025 11:07:34

HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on Edgewise Therapeutics (NASDAQ:EWTX) with a Buy rating...

no-accelerated-fda-approval-for-edgewises-rare-muscular-disease-drug-shares-fall

No Accelerated FDA Approval For Edgewise's...
06/26/2025 17:29:30

Edgewise reports sustained functional stability in Becker patients and selects Phase 3 dose for Duchenne after positive Phase 2...

Edgewise Therapeutics Reports Results in S...
06/26/2025 10:04:07

Edgewise Therapeutics, Inc., (NASDAQ:EWTX), a leading muscle disease biopharmaceutical company, today unveiled positive results...

RBC Capital Reiterates Outperform on Edgew...
06/05/2025 14:05:55

RBC Capital analyst Leonid Timashev reiterates Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and maintains $48 price...

12 Health Care Stocks Moving In Monday's P...
05/12/2025 12:08:42

Edgewise Therapeutics Q1 EPS $(0.43), Inline
05/08/2025 12:04:28

Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.43) per share which met the analyst consensus estimate. Th...

Wedbush Maintains Outperform on Edgewise T...
04/21/2025 15:13:01

Wedbush analyst Laura Chico maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and maintains $43 price target.

tesla-nvidia-apple-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

Tesla, Nvidia, Apple And Other Big Stocks ...
04/21/2025 12:24:45

top-3-health-care-stocks-that-could-lead-to-your-biggest-gains-in-q2

Top 3 Health Care Stocks That Could Lead T...
04/10/2025 10:56:54

RBC Capital Maintains Outperform on Edgewi...
04/03/2025 15:17:56

RBC Capital analyst Leonid Timashev maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and lowers the price tar...

Scotiabank Downgrades Edgewise Therapeutic...
04/03/2025 14:29:20

Scotiabank analyst Louise Chen downgrades Edgewise Therapeutics (NASDAQ:EWTX) from Sector Outperform to Sector Perform and l...

Piper Sandler Maintains Overweight on Edge...
04/02/2025 17:53:26

Piper Sandler analyst Yasmeen Rahimi maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Overweight and maintains $51 price...